In addition, CD133 depletion frequently is accompanied by the suppressed expression of the pluripotent stem genes and slow proliferation phenotype in cancer [4, 215, 216], which suggests that CD133 downregulation could impact several cellular processes via dependent and independent of PI3K/Akt signaling in a context-dependent manner. The gene discussed is AKT1; the disease is cancer.